Reported Earnings • May 26
Third quarter 2026 earnings released: RM0.023 loss per share (vs RM0.055 loss in 3Q 2025) Third quarter 2026 results: RM0.023 loss per share (improved from RM0.055 loss in 3Q 2025). Revenue: RM20.5m (down 54% from 3Q 2025). Net loss: RM18.0m (loss narrowed 59% from 3Q 2025). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 48 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Apr 23
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 27% to RM0.21. The fair value is estimated to be RM0.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Mar 02
Second quarter 2026 earnings released: RM0.088 loss per share (vs RM0.055 loss in 2Q 2025) Second quarter 2026 results: RM0.088 loss per share (further deteriorated from RM0.055 loss in 2Q 2025). Revenue: RM25.8m (down 43% from 2Q 2025). Net loss: RM68.7m (loss widened 58% from 2Q 2025). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 30 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Feb 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 28% to RM0.21. The fair value is estimated to be RM0.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.9% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Nov 27
First quarter 2026 earnings released: RM0.055 loss per share (vs RM0.013 profit in 1Q 2025) First quarter 2026 results: RM0.055 loss per share (down from RM0.013 profit in 1Q 2025). Revenue: RM34.3m (down 33% from 1Q 2025). Net loss: RM42.3m (down RM52.5m from profit in 1Q 2025). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 9.8% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 16 percentage points per year, which is a significant difference in performance. New Risk • Nov 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Malaysian stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Market cap is less than US$100m (RM313.5m market cap, or US$75.1m). Reported Earnings • Oct 26
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: RM0.04 loss per share (down from RM0.09 profit in FY 2024). Revenue: RM222.7m (down 20% from FY 2024). Net loss: RM31.4m (down 146% from profit in FY 2024). Revenue missed analyst estimates by 8.1%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 8.8% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 40% per year whereas the company’s share price has fallen by 37% per year. 공고 • Oct 23
Genetec Technology Berhad, Annual General Meeting, Nov 25, 2025 Genetec Technology Berhad, Annual General Meeting, Nov 25, 2025, at 10:00 Singapore Standard Time. Location: halls jade 1 & 2, jade hills resort club, persiaran jade hills utama, jade hills, 43000 kajang, selangor darul ehsan, Malaysia Reported Earnings • Sep 02
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: RM0.043 loss per share (down from RM0.09 profit in FY 2024). Revenue: RM222.7m (down 20% from FY 2024). Net loss: RM33.6m (down 149% from profit in FY 2024). Revenue missed analyst estimates by 8.1%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 9.1% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has fallen by 41% per year whereas the company’s share price has fallen by 40% per year. New Risk • Aug 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.1% average weekly change). Buy Or Sell Opportunity • Aug 19
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 46% to RM0.56. The fair value is estimated to be RM0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.6% over the last year. Earnings per share has declined by 2.9%. For the next 3 years, revenue is forecast to grow by 6.3% per annum. Earnings are also forecast to grow by 1.4% per annum over the same time period. Buy Or Sell Opportunity • Jul 03
Now 24% overvalued Over the last 90 days, the stock has fallen 16% to RM0.94. The fair value is estimated to be RM0.76, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 6.6% over the last year. Earnings per share has declined by 2.9%. For the next 3 years, revenue is forecast to grow by 6.3% per annum. Earnings are also forecast to grow by 1.4% per annum over the same time period. New Risk • Jun 18
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (9.8% average weekly change). Major Estimate Revision • May 30
Consensus EPS estimates fall by 32% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from RM271.4m to RM250.6m. EPS estimate also fell from RM0.072 per share to RM0.049 per share. Net income forecast to shrink 44% next year vs 41% growth forecast for Semiconductor industry in Malaysia . Consensus price target down from RM2.00 to RM1.30. Share price fell 2.5% to RM0.99 over the past week. New Risk • May 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Valuation Update With 7 Day Price Move • May 14
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to RM1.17, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 22x in the Semiconductor industry in Malaysia. Total loss to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at RM1.57 per share. Buy Or Sell Opportunity • Apr 03
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 25% to RM1.10. The fair value is estimated to be RM1.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 28%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to RM1.22, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 21x in the Semiconductor industry in Malaysia. Total loss to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at RM1.46 per share. Buy Or Sell Opportunity • Feb 25
Now 22% undervalued Over the last 90 days, the stock has risen 1.7% to RM1.19. The fair value is estimated to be RM1.52, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 28%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 16% per annum over the same time period. Valuation Update With 7 Day Price Move • Feb 24
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to RM1.23, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 21x in the Semiconductor industry in Malaysia. Total loss to shareholders of 46% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at RM1.52 per share. Valuation Update With 7 Day Price Move • Feb 06
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to RM1.61, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 25x in the Semiconductor industry in Malaysia. Total loss to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at RM1.64 per share. Buy Or Sell Opportunity • Feb 05
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 69% to RM1.56. The fair value is estimated to be RM1.30, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 28%. For the next 3 years, revenue is forecast to grow by 13% per annum. Earnings are also forecast to grow by 14% per annum over the same time period. Buy Or Sell Opportunity • Jan 21
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 104% to RM1.57. The fair value is estimated to be RM1.28, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 28%. For the next 3 years, revenue is forecast to grow by 13% per annum. Earnings are also forecast to grow by 14% per annum over the same time period. Major Estimate Revision • Dec 03
Consensus revenue estimates fall by 30% The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from RM348.1m to RM244.4m. EPS estimate fell from RM0.11 to RM0.063 per share. Net income forecast to shrink 30% next year vs 52% growth forecast for Semiconductor industry in Malaysia . Consensus price target down from RM3.75 to RM1.83. Share price rose 43% to RM1.25 over the past week. Valuation Update With 7 Day Price Move • Nov 27
Investor sentiment improves as stock rises 41% After last week's 41% share price gain to RM1.17, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 25x in the Semiconductor industry in Malaysia. Total loss to shareholders of 60% over the past three years. New Risk • Nov 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Malaysian stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risk Dividend is not well covered by cash flows (99% cash payout ratio). 공고 • Nov 06
Tan Moon Teik agreed to acquire an additional 51% stake in Clt Engineering Sdn Bhd from Genetec Technology Berhad (KLSE:GENETEC) for MYR 21.6 million. Tan Moon Teik agreed to acquire an additional 51% stake in Clt Engineering Sdn Bhd from Genetec Technology Berhad (KLSE:GENETEC) for MYR 21.6 million on November 4, 2024. A cash consideration of MYR 2.16 million will be paid by the buyer. The buyer will pay an earnout/contingent payment of MYR 19.46 million cash. As part of consideration, MYR 21.63 million is paid towards common equity of Clt Engineering Sdn Bhd.
As of June 30, 2024, Clt Engineering Sdn Bhd reported total common equity of MYR 31.92 million.
The transaction is subject to approval of offer by target shareholders. The expected completion of the transaction is first quarter of 2025.
Malacca Securities Sdn Bhd acted as financial advisor for Genetec Technology Berhad. TA Securities Holdings Berhad acted as financial advisor for Genetec Technology Berhad. Reported Earnings • Oct 30
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: RM0.09. Revenue: RM277.6m (down 6.6% from FY 2023). Net income: RM68.9m (up 5.2% from FY 2023). Profit margin: 25% (up from 22% in FY 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 7.4%. Earnings per share (EPS) also missed analyst estimates by 7.7%. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Semiconductor industry in Malaysia. 공고 • Oct 25
Genetec Technology Berhad, Annual General Meeting, Nov 26, 2024 Genetec Technology Berhad, Annual General Meeting, Nov 26, 2024, at 10:00 Singapore Standard Time. Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to RM1.03, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 25x in the Semiconductor industry in Malaysia. Total loss to shareholders of 63% over the past three years. New Risk • Sep 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (98% cash payout ratio). Share price has been volatile over the past 3 months (8.0% average weekly change). Shareholders have been diluted in the past year (2.6% increase in shares outstanding). New Risk • Sep 17
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (2.6% increase in shares outstanding). Upcoming Dividend • Sep 05
Upcoming dividend of RM0.02 per share Eligible shareholders must have bought the stock before 12 September 2024. Payment date: 04 October 2024. The company last paid an ordinary dividend in August 2018. The average dividend yield among industry peers is 1.7%. 공고 • Aug 30
Genetec Technology Berhad Declares Interim Single-Tier Dividend for the Financial Period Ended 30 June 2024, Payable on 4 October 2024 Genetec Technology Berhad declared an interim single-tier dividend of 2.0 sen per ordinary share in respect of the financial period ended 30 June 2024. The interim single-tier dividend will be paid on 4 October 2024 to the shareholders whose names appear in the Record of Depositors on 13 September 2024. Price Target Changed • Aug 27
Price target decreased by 7.4% to RM3.75 Down from RM4.05, the current price target is an average from 2 analysts. New target price is 250% above last closing price of RM1.07. Stock is down 55% over the past year. The company is forecast to post earnings per share of RM0.07 for next year compared to RM0.10 last year. Valuation Update With 7 Day Price Move • Aug 21
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to RM1.56, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 30x in the Semiconductor industry in Malaysia. Total loss to shareholders of 25% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at RM2.40 per share. Buy Or Sell Opportunity • Aug 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 2.1% to RM1.91. The fair value is estimated to be RM2.43, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 83% in 2 years. Earnings are forecast to grow by 66% in the next 2 years. Reported Earnings • May 29
Full year 2024 earnings released: EPS: RM0.10 (vs RM0.097 in FY 2023) Full year 2024 results: EPS: RM0.10 (up from RM0.097 in FY 2023). Revenue: RM295.5m (flat on FY 2023). Net income: RM76.0m (up 14% from FY 2023). Profit margin: 26% (up from 23% in FY 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 100% per year, which means it is tracking significantly ahead of earnings growth. Buy Or Sell Opportunity • May 06
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 5.8% to RM2.01. The fair value is estimated to be RM1.64, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings are also forecast to grow by 18% per annum over the same time period. Reported Earnings • Feb 28
Third quarter 2024 earnings released: EPS: RM0.031 (vs RM0.019 in 3Q 2023) Third quarter 2024 results: EPS: RM0.031 (up from RM0.019 in 3Q 2023). Revenue: RM76.9m (down 9.7% from 3Q 2023). Net income: RM23.3m (up 83% from 3Q 2023). Profit margin: 30% (up from 15% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has increased by 72% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Feb 26
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to RM2.16, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 28x in the Semiconductor industry in Malaysia. Total returns to shareholders of 376% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at RM1.67 per share. Buy Or Sell Opportunity • Feb 22
Now 22% overvalued Over the last 90 days, the stock has fallen 14% to RM2.05. The fair value is estimated to be RM1.68, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 41% over the last 3 years. Earnings per share has grown by 71%. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings are also forecast to grow by 20% per annum over the same time period. Reported Earnings • Nov 29
Second quarter 2024 earnings released: EPS: RM0.025 (vs RM0.037 in 2Q 2023) Second quarter 2024 results: EPS: RM0.025 (down from RM0.037 in 2Q 2023). Revenue: RM72.4m (up 2.5% from 2Q 2023). Net income: RM18.5m (down 26% from 2Q 2023). Profit margin: 26% (down from 36% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has increased by 162% per year, which means it is tracking significantly ahead of earnings growth. 공고 • Aug 30
Genetec Technology Berhad, Annual General Meeting, Sep 29, 2023 Genetec Technology Berhad, Annual General Meeting, Sep 29, 2023, at 10:00 Singapore Standard Time. Agenda: To receive the Audited Financial Statements for the financial year ended 31 March 2023 together with the Reports of the Directors and Auditors thereon; to approve the payment of Directors' fees of RMB 392,000 payable to the Non-Executive Directors for the financial year ending 31 March 2024; to re-elect Mr Hew Voon Foo who is due to retire pursuant to Clause 105 of the Company's Constitution and being eligible, has offered himself for re-election; to appoint Messrs Baker Tilly Monteiro Heng PLT as Auditors of Company in place of retiring Auditors, Messrs KPMG PLT and to authorise the Directors to fix their remuneration; and to discuss other matters. Reported Earnings • Aug 02
Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat Full year 2023 results: EPS: RM0.097 (up from RM0.083 in FY 2022). Revenue: RM294.6m (up 32% from FY 2022). Net income: RM66.6m (up 18% from FY 2022). Profit margin: 23% (down from 25% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has increased by 174% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jun 02
Full year 2023 earnings released: EPS: RM0.11 (vs RM0.083 in FY 2022) Full year 2023 results: EPS: RM0.11 (up from RM0.083 in FY 2022). Revenue: RM307.4m (up 38% from FY 2022). Net income: RM73.4m (up 30% from FY 2022). Profit margin: 24% (down from 25% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has increased by 191% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 28
Third quarter 2023 earnings released: EPS: RM0.019 (vs RM0.028 in 3Q 2022) Third quarter 2023 results: EPS: RM0.019 (down from RM0.028 in 3Q 2022). Revenue: RM85.1m (up 31% from 3Q 2022). Net income: RM12.8m (down 30% from 3Q 2022). Profit margin: 15% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 107% per year but the company’s share price has increased by 197% per year, which means it is tracking significantly ahead of earnings growth. Major Estimate Revision • Feb 17
Consensus EPS estimates fall by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from RM323.4m to RM298.4m. EPS estimate also fell from RM0.125 per share to RM0.111 per share. Net income forecast to grow 15% next year vs 15% growth forecast for Semiconductor industry in Malaysia. Consensus price target broadly unchanged at RM4.53. Share price fell 3.8% to RM2.75 over the past week. 공고 • Feb 15
Genetec Technology Berhad has completed a Follow-on Equity Offering in the amount of MYR 177.99203 million. Genetec Technology Berhad has completed a Follow-on Equity Offering in the amount of MYR 177.99203 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 68,196,180
Price\Range: MYR 2.61
Transaction Features: Subsequent Direct Listing Price Target Changed • Dec 29
Price target increased to RM4.50 Up from RM4.00, the current price target is an average from 2 analysts. New target price is 88% above last closing price of RM2.40. Stock is down 23% over the past year. The company is forecast to post earnings per share of RM0.12 for next year compared to RM0.083 last year. Reported Earnings • Dec 03
Second quarter 2023 earnings released: EPS: RM0.037 (vs RM0.025 in 2Q 2022) Second quarter 2023 results: EPS: RM0.037 (up from RM0.025 in 2Q 2022). Revenue: RM70.7m (up 19% from 2Q 2022). Net income: RM25.1m (up 54% from 2Q 2022). Profit margin: 36% (up from 28% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Semiconductor industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has increased by 227% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 01
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: RM0.083 (up from RM0.006 loss in FY 2021). Revenue: RM223.6m (up 130% from FY 2021). Net income: RM56.4m (up RM60.6m from FY 2021). Profit margin: 25% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.3%. Over the next year, revenue is forecast to grow 35%, compared to a 19% growth forecast for the industry in Malaysia. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has increased by 204% per year, which means it is tracking significantly ahead of earnings growth. 공고 • Jul 28
Genetec Technology Berhad, Annual General Meeting, Aug 29, 2022 Genetec Technology Berhad, Annual General Meeting, Aug 29, 2022, at 10:00 Singapore Standard Time. Agenda: To approve additional payment of Directors’ fees for the financial year ended 31 March 2022; to approve payment of Directors’ fees for the financial year ending 31 March 2023; to re-elect Chin Kem Weng as Director; to re-elect Sow Ewe Lee as Director; to re-elect Dato’ Jeeventhiran a/l Ramanaidu as Director; to re-appoint KPMG PLT as Auditors for the ensuing year and to authorize the Directors to fix their remuneration; to retain Hew Voon Foo as an Independent Non-Executive Director; to retain Teh Kim Seng as an Independent Non-Executive Director; and to consider other matters. Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment improved over the past week After last week's 17% share price gain to RM2.25, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 19x in the Semiconductor industry in Malaysia. Total returns to shareholders of 2,298% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at RM2.36 per share. 
